U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 51

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr1:45478659
GRCh38:
Chr1:45012987
URODW34*Familial porphyria cutanea tardaLikely pathogenicno assertion criteria provided
2.
GRCh37:
Chr1:45478628
GRCh38:
Chr1:45012956
URODW24GFamilial porphyria cutanea tardaUncertain significance
(Jan 24, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr1:45479722
GRCh38:
Chr1:45014050
URODQ206*Familial porphyria cutanea tarda, not providedPathogenic/Likely pathogenic
(Mar 1, 2023)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr1:45478812
GRCh38:
Chr1:45013140
URODF46LFamilial porphyria cutanea tardaLikely pathogenic
(Oct 6, 2021)
criteria provided, single submitter
5.
GRCh37:
Chr1:45479689-45479717
GRCh38:
Chr1:45014017-45014045
URODL195fsFamilial porphyria cutanea tardaLikely pathogenic
(Apr 30, 2021)
criteria provided, single submitter
6.
GRCh37:
Chr6:26093461
GRCh38:
Chr6:26093233
HFEHemochromatosis type 1, not provided, Familial porphyria cutanea tarda,
Hemochromatosis type 1, Microvascular complications of diabetes, susceptibility to, 7, Transferrin serum level quantitative trait locus 2,
Variegate porphyria, Alzheimer disease type 1, Hereditary hemochromatosis
Pathogenic/Likely pathogenic
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr1:45478578
GRCh38:
Chr1:45012906
URODFamilial porphyria cutanea tardaPathogenic
(May 3, 2020)
criteria provided, single submitter
8.
GRCh37:
Chr6:26095057
GRCh38:
Chr6:26094829
HFEHemochromatosis type 1, Microvascular complications of diabetes, susceptibility to, 7, Alzheimer disease type 1,
Hemochromatosis type 1, Transferrin serum level quantitative trait locus 2, Familial porphyria cutanea tarda,
Variegate porphyria
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr6:26094652
GRCh38:
Chr6:26094424
HFEHemochromatosis type 1, Microvascular complications of diabetes, susceptibility to, 7, Alzheimer disease type 1,
Hemochromatosis type 1, Transferrin serum level quantitative trait locus 2, Familial porphyria cutanea tarda,
Variegate porphyria
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr1:45478567
GRCh38:
Chr1:45012895
URODFamilial porphyria cutanea tardaUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
11.
GRCh37:
Chr1:45481240
GRCh38:
Chr1:45015568
URODFamilial porphyria cutanea tardaUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
12.
GRCh37:
Chr1:45481018
GRCh38:
Chr1:45015346
URODG318Rnot specified, not provided, Familial porphyria cutanea tarda
Conflicting interpretations of pathogenicity
(Oct 26, 2022)
criteria provided, conflicting interpretations
13.
GRCh37:
Chr1:45480260
GRCh38:
Chr1:45014588
URODnot provided, Familial porphyria cutanea tardaConflicting interpretations of pathogenicity
(Oct 24, 2022)
criteria provided, conflicting interpretations
14.
GRCh37:
Chr1:45480219
GRCh38:
Chr1:45014547
URODR249WFamilial porphyria cutanea tarda, not providedUncertain significance
(Sep 25, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr1:45480153
GRCh38:
Chr1:45014481
URODQ227EFamilial porphyria cutanea tardaUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr1:45479684
GRCh38:
Chr1:45014012
URODR193HFamilial porphyria cutanea tardaUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
17.
GRCh37:
Chr1:45479667
GRCh38:
Chr1:45013995
URODFamilial porphyria cutanea tardaUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr1:45479452
GRCh38:
Chr1:45013780
URODA155TFamilial porphyria cutanea tardaUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
19.
GRCh37:
Chr1:45479431
GRCh38:
Chr1:45013759
URODR148Cnot provided, Familial porphyria cutanea tardaUncertain significance
(Mar 20, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr1:45479379
GRCh38:
Chr1:45013707
URODE130Dnot provided, Familial porphyria cutanea tardaUncertain significance
(Feb 9, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr1:45479372
GRCh38:
Chr1:45013700
URODA128Dnot provided, Familial porphyria cutanea tardaUncertain significance
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr1:45478990
GRCh38:
Chr1:45013318
URODFamilial porphyria cutanea tardaUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
23.
GRCh37:
Chr1:45478585
GRCh38:
Chr1:45012913
URODQ9HFamilial porphyria cutanea tardaUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
24.
GRCh37:
Chr1:45480640
GRCh38:
Chr1:45014968
URODQ302*Familial porphyria cutanea tardaPathogenic
(May 28, 2019)
criteria provided, single submitter
25.
GRCh37:
Chr1:45478832
GRCh38:
Chr1:45013160
URODQ53RFamilial porphyria cutanea tarda, not providedConflicting interpretations of pathogenicity
(Apr 17, 2018)
criteria provided, conflicting interpretations
26.
GRCh37:
Chr6:26092972
GRCh38:
Chr6:26092744
HFER226W, R138W, R212W, R46W, R124W, R203W, R120W, R134W, R223WAlzheimer disease type 1, Microvascular complications of diabetes, susceptibility to, 7, Variegate porphyria,
Hemochromatosis type 1, Transferrin serum level quantitative trait locus 2, Familial porphyria cutanea tarda,
Hemochromatosis type 1
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr6:26093062
GRCh38:
Chr6:26092834
HFEV256I, V154I, V164I, V168I, V233I, V242I, V150I, V76I, V253IHemochromatosis type 1, Hereditary hemochromatosis, Microvascular complications of diabetes, susceptibility to, 7,
Hemochromatosis type 1, Transferrin serum level quantitative trait locus 2, Familial porphyria cutanea tarda,
Variegate porphyria, Alzheimer disease type 1
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr6:26091747-26091748
GRCh38:
Chr6:26091519-26091520
HFEL183fs, L95fs, L160fsHemochromatosis type 1, Variegate porphyria, Microvascular complications of diabetes, susceptibility to, 7,
Familial porphyria cutanea tarda, Hemochromatosis type 1, Transferrin serum level quantitative trait locus 2,
Alzheimer disease type 1, Hereditary hemochromatosis
Pathogenic/Likely pathogenic
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr1:45481215
GRCh38:
Chr1:45015543
URODFamilial porphyria cutanea tardaUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
30.
GRCh37:
Chr1:45480232
GRCh38:
Chr1:45014560
URODL253QFamilial porphyria cutanea tarda, not providedConflicting interpretations of pathogenicity
(Oct 5, 2022)
criteria provided, conflicting interpretations
31.
GRCh37:
Chr1:45480212
GRCh38:
Chr1:45014540
URODFamilial porphyria cutanea tardaUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
32.
GRCh37:
Chr1:45480167
GRCh38:
Chr1:45014495
URODFamilial porphyria cutanea tardaUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
33.
GRCh37:
Chr1:45479478
GRCh38:
Chr1:45013806
URODnot provided, Familial porphyria cutanea tardaConflicting interpretations of pathogenicity
(Apr 5, 2021)
criteria provided, conflicting interpretations
34.
GRCh37:
Chr1:45479439
GRCh38:
Chr1:45013767
URODnot provided, Familial porphyria cutanea tardaBenign/Likely benign
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr1:45477937
GRCh38:
Chr1:45012265
URODFamilial porphyria cutanea tardaUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
36.
GRCh37:
Chr1:45479709
GRCh38:
Chr1:45014037
URODFamilial porphyria cutanea tarda, not provided, not specified
Benign
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr1:45481173
GRCh38:
Chr1:45015501
URODFamilial porphyria cutanea tarda, not specified, not provided
Conflicting interpretations of pathogenicity
(Oct 25, 2022)
criteria provided, conflicting interpretations
38.
GRCh37:
Chr1:45479684
GRCh38:
Chr1:45014012
URODR193PUROD-Related Disorders, not providedLikely pathogenic
(Dec 12, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr6:26091703
GRCh38:
Chr6:26091475
HFEE168Q, E80Q, E145QHereditary hemochromatosis, Hemochromatosis type 1, not provided,
Familial porphyria cutanea tarda, Hemochromatosis type 1, Transferrin serum level quantitative trait locus 2,
Variegate porphyria, Microvascular complications of diabetes, susceptibility to, 7, Alzheimer disease type 1
Uncertain significance
(Sep 8, 2023)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr6:26087686
GRCh38:
Chr6:26087458
HFE-AS1, HFER6SHemochromatosis type 1, Hereditary hemochromatosis, not provided,
Variegate porphyria, Microvascular complications of diabetes, susceptibility to, 7, Alzheimer disease type 1,
Hemochromatosis type 1, Transferrin serum level quantitative trait locus 2, Familial porphyria cutanea tarda
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr1:45481061
GRCh38:
Chr1:45015389
URODR332HFamilial porphyria cutanea tardaConflicting interpretations of pathogenicity
(May 4, 2022)
criteria provided, conflicting interpretations
42.
GRCh37:
Chr1:45480648
GRCh38:
Chr1:45014976
URODN304Knot providedPathogenic
(Jul 15, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr1:45479689
GRCh38:
Chr1:45014017
URODL195FFamilial porphyria cutanea tardaPathogenic
(Nov 1, 1998)
no assertion criteria provided
44.
GRCh37:
Chr1:45479600
GRCh38:
Chr1:45013928
URODM165RFamilial porphyria cutanea tardaPathogenic
(Nov 1, 1998)
no assertion criteria provided
45.
GRCh37:
Chr1:45480678
GRCh38:
Chr1:45015006
URODnot providedLikely pathogenic
(Jul 14, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr1:45479743
GRCh38:
Chr1:45014071
URODnot providedPathogenic
(Feb 9, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr1:45480475
GRCh38:
Chr1:45014803
URODG281EPorphyria cutanea tarda, Hepatoerythropoietic porphyriaPathogenic
(Apr 1, 1996)
no assertion criteria provided
48.
GRCh37:
Chr1:45480475
GRCh38:
Chr1:45014803
URODG281Vnot providedPathogenic
(Sep 27, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr6:26091185
GRCh38:
Chr6:26090957
HFE, HFE-AS1S65C, S42CHemochromatosis type 1, Hereditary hemochromatosis, not provided,
not specified, Variegate porphyria, Microvascular complications of diabetes, susceptibility to, 7,
Hemochromatosis type 1, Transferrin serum level quantitative trait locus 2, Familial porphyria cutanea tarda,
Alzheimer disease type 1, Variegate porphyriaMicrovascular complications of diabetes, susceptibility to, 7,
Alzheimer disease, Hemochromatosis type 1, Transferrin serum level quantitative trait locus 2,
Familial porphyria cutanea tarda, ...see more
Conflicting interpretations of pathogenicity
(Jun 1, 2023)
criteria provided, conflicting interpretations
50.
GRCh37:
Chr6:26091179
GRCh38:
Chr6:26090951
HFE, HFE-AS1H63D, H40Dnot specified, Hemochromatosis type 1, Hereditary hemochromatosis,
not provided, Cardiomyopathy, Variegate porphyria,
Abnormality of iron homeostasis, Variegate porphyria, Microvascular complications of diabetes, susceptibility to, 7,
Alzheimer disease, Hemochromatosis type 1Transferrin serum level quantitative trait locus 2,
Familial porphyria cutanea tarda, See cases, ...see more
Conflicting interpretations of pathogenicity; other
(Aug 15, 2023)
criteria provided, conflicting interpretations
51.
GRCh37:
Chr6:26093141
GRCh38:
Chr6:26092913
HFEC282Y, C176Y, C180Y, C190Y, C194Y, C259Y, C268Y, C102Y, C279YHFE-related disorder, Abnormal peripheral nervous system morphology, Abnormality of the male genitalia,
Abdominal pain, Atypical behavior, Abnormality of the nervous system,
Pain, Peripheral neuropathy, Inborn genetic diseases,
Hemochromatosis type 1, Hemochromatosis type 2Hereditary hemochromatosis,
Hereditary cancer-predisposing syndrome, not provided, Cardiomyopathy,
Variegate porphyria, Microvascular complications of diabetes, susceptibility to, 7, Hemochromatosis type 1,
Transferrin serum level quantitative trait locus 2, Familial porphyria cutanea tarda, Alzheimer disease type 1,
Cutaneous photosensitivity, Porphyrinuria, ...see more
Conflicting interpretations of pathogenicity; other; risk factor
(Aug 15, 2023)
criteria provided, conflicting interpretations
Format
Items per page
Sort by
Choose Destination